Contributors

Article

Thomas E. Ahlering, MD Urology Division University of California, Irvine Medical Center Steven R. Alberts, MD Division of Medical Oncology Mayo Clinic Penny R. Anderson, MD Department of Radiation Oncology Fox Chase Cancer Center Andrew J. Armstrong, MD Department of Medicine Duke University Medical Center Al B. Benson III, MD Division of Hematology/Oncology Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine/ Northwestern University J. Sybil Biermann, MD Department of Orthopaedic Surgery University of Michigan Comprehensive Cancer Center Charles D. Blanke, MD Department of Medicine The University of British Columbia Deborah Bradley Division of Hematology/Oncology University of Michigan Ilana Braun, MD Department of Oncologic Psychiatry Massachusetts General Hospital Eduardo Bruera, MD Department of Palliative Care and Rehabilitation Medicine M. D. Anderson Cancer Center
Mark Buyyounouski, MD Department of Radiation Oncology Fox Chase Cancer Center Emiliano Calvo, MD, PhD Division of Medical Oncology Centro Integral Oncolgico Clara Campal Kevin A. Camphausen, MD Radiation Oncology Branch National Cancer Institute Dennis S. Chi, MD Gynecology Service Memorial Sloan-Kettering Cancer Center Brian C. -H. Chiu, PhD Department of Preventive Medicine Northwestern University Warren Chow, MD Department of Medical Oncology City of Hope National Medical Center Deborah E. Citrin, MD Radiation Oncology Branch National Cancer Institute Lawrence R. Coia, MD Southern Ocean County Radiation Oncology Manahawkin, New Jersey Jay S. Cooper, MD Department of Radiation Oncology Maimonides Medical Center Jorge E. Cortes, MD Department of Leukemia M. D. Anderson Cancer Center Jeffrey Crawford, MD Department of Medical Oncology Duke University Medical Center

Carey A. Cullinane, MD Department of Surgical Oncology Long Beach Memorial Medical Center Lisa M. DeAngelis, MD Department of Neurology Memorial Sloan-Kettering Cancer Center Lawrence Driver, MD Pain Symptom Management Section M. D. Anderson Cancer Center Joshua D. I. Ellenhorn, MD Division of Surgery City of Hope National Medical Center Carmen P. Escalante, MD Department of General Internal Medicine, Ambulatory Treatment, and Emergency Care M. D. Anderson Cancer Center Richard Essner, MD Division of Surgery John Wayne Cancer Institute Andrew M. Evens, DO Division of Hematology/Oncology Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine/ Northwestern University Steven J. Feigenberg, MD Department of Radiation Oncology Fox Chase Cancer Center Paul Fisher, MD Department of Radiology Stony Brook University Medical Center Keith Flaherty, MD Division of Hematology/Oncology Abramson Cancer Center of the University of Pennsylvania Stephen J. Forman, MD Division of Hematology and Bone Marrow Transplantation City of Hope National Medical Center
Deborah Frassica, MD Department of Radiation Oncology The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Guillermo Garcia-Manero Department of Leukemia M. D. Anderson Cancer Center Bonnie S. Glisson, MD Department of Thoracic/ Head and Neck Medical Oncology M. D. Anderson Cancer Center Leo I. Gordon, MD Division of Hematology/Oncology Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine/ Northwestern University Richard J. Gralla, MD Division of Hematology/Oncology North Shore University Hospital and LIJ Medical Center Frederic W. Grannis, Jr., MD Section of Thoracic Surgery City of Hope National Medical Center Kathryn M. Greven, MD Department of Radiation Oncology Wake Forest University School of Medicine Steven M. Grunberg, MD Division of Medical Oncology University of Vermont Bruce G. Haffty, MD Department of Radiation Oncology UMDNJ - Robert Wood Johnson Medical School The Cancer Institute of New Jersey John D. Hainsworth, MD Department of Clinical Research Sarah Cannon Research Institute Nashville, Tennessee Brent K. Hollenbeck, MD Department of Medicine/Urology University of Michigan Comprehensive Cancer Center

Eric M. Horwitz, MD Department of Radiation Oncology Fox Chase Cancer Center William J. Hoskins, MD Department of Surgery Memorial Sloan-Kettering Cancer Center Mimi Hu, MD Department of Endocrine Neoplasia and Hormonal Disorders M. D. Anderson Cancer Center Mark Hurwitz, MD Department of Radiation Oncology Brigham and Women’s Hospital Maha Hussain, MD Division of Hematology/Oncology University of Michigan Comprehensive Cancer Center Jimmy J. Hwang, MD Division of Hematology/Oncology Lombardi Comprehensive Cancer Center Georgetown University Medical Center James Ito, Jr., MD Department of Infectious Diseases City of Hope National Medical Center Rajesh V. Iyer, MD Department of Radiation Oncology Community Medical Center Saint Barnabas Health Care System Sundar Jagannath, MD Myeloma and Transplant St. Vincent’s Comprehensive Cancer Center Ishmael Jaiyesimi, DO Division of Hematology/Oncology William Beaumont Hospital Lori Jardines, MD Department of Surgery Albert Einstein Medical Center Aminah Jatoi, MD Department of Medical Oncology Mayo Clinic
Hagop Kantarjian, MD Department of Leukemia M. D. Anderson Cancer Center Aradhana Kaushal, MD Radiation Oncology Branch National Cancer Institute John J. Kavanagh, MD Department of Gynecologic Oncology M. D. Anderson Cancer Center Kemp H. Kernstine, MD, PhD Department of Thoracic Surgery City of Hope National Medical Center Fadlo R. Khuri, MD Department of Hematology/Oncology Winship Cancer Institute of Emory University Lily Lai, MD Division of Surgery City of Hope National Medical Center Mario E. Lacouture, MD Department of Dermatology Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine/ Northwestern University Nicole Lamanna, MD Department of Medicine/ Leukemia Service Memorial Sloan-Kettering Cancer Center Jeffrey P. Lamont, MD Department of Surgery Baylor University Medical Center Miriam N. Lango, MD Department of Surgical Oncology Fox Chase Cancer Center Joseph Lattanzi, MD Southern Ocean County Radiation Oncology Manahawkin, New Jersey

Alan List, MD Department of Hematologic Malignancies H. Lee Moffitt Cancer Center and Research Institute Jay S. Loeffler, MD Department of Radiation Oncology Massachusetts General Hospital Patrick J. Loehrer, MD Division of Hematology/Oncology Indiana University Cancer Center Charles Loprinzi, MD Department of Medical Oncology Mayo Clinic Robert Lustig, MD Department of Radiation Oncology University of Pennsylvania Robert Maki, MD, PhD Department of Medicine Memorial Sloan-Kettering Cancer Center Adam N. Mamelak, MD Division of Neurosurgery Cedars-Sinai Medical Center Gary N. Mann, MD Division of Surgery University of Washington Ellen Manzullo, MD Department of General Internal Medicine, Ambulatory Treatment, and Emergency Care M. D. Anderson Cancer Center Maurie Markman, MD Department of Clinical Research M. D. Anderson Cancer Center David Scott Miller, MD Division of Gynecologic Oncology University of Texas Southwestern Medical Center Ronald T. Mitsuyasu, MD Department of Medicine UCLA CARE Center
Judd W. Moul, MD Division of Urologic Surgery Duke University Medical Center Benjamin Movsas, MD Department of Radiation Oncology Henry Ford Health System Michael S. Mulligan, MD Department of Surgery University of Washington Nikhil C. Munshi, MD Department of Adult Oncology Dana-Farber Cancer Institute Robert J. Myerson, MD, PhD Department of Radiation Oncology Washington University Margaret R. O’Donnell, MD Department of Hematology/ Hematopoietic Stem Cell Transplantation City of Hope National Medical Center Bert O’Neil, MD Department of Medicine University of North Carolina at Chapel Hill Richard Pazdur, MD Office of Oncology Drug Products Center for Drug Evaluation and Research US Food and Drug Administration Carlos A. Perez, MD Department of Radiation Oncology Washington University School of Medicine Louis L. Pisters, MD Department of Urology M. D. Anderson Cancer Center Peter W. T. Pisters, MD Division of Surgery M. D. Anderson Cancer Center Stephen P. Povoski, MD Division of Surgery The Ohio State University

Bruce G. Redman, DO Division of Hematology/Oncology University of Michigan Comprehensive Cancer Center Paul Richardson, MD Department of Medical Oncology/ Hematologic Malignancies Dana-Farber Cancer Institute John Andrew Ridge, MD, PhD Department of Surgical Oncology Fox Chase Cancer Center Brian I. Rini, MD Department of Solid Tumor Oncology and Urology Cleveland Clinic Taussig Cancer Center John M. Robertson, MD Department of Radiation Oncology William Beaumont Hospital Steven T. Rosen, MD Division of Hematology/Oncology Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine/ Northwestern University Melanie Royce, MD, PhD Division of Hematology/Oncology University of New Mexico Cancer Research and Treatment Center Stephen C. Rubin, MD Division of Gynecologic Oncology Hospital of the University of Pennsylvania Paul Sabbatini, MD Gynecologic Section Solid Tumor Division Memorial Sloan-Kettering Cancer Center Aaron Sasson, MD Department of Surgery University of Nebraska Medical Center Roderich E. Schwarz, MD, PhD Department of Surgery University of Texas Southwestern Medical Center
Walter Scott, MD Department of Thoracic Surgical Oncology Fox Chase Cancer Center Richard T. Silver, MD Department of Medicine Weill Cornell Medical College Douglas Skarecky, BS Department of Urology University of California, Irvine Medical Center Philippe E. Spiess, MD Department of Genitourinary Oncology H. Lee Moffitt Cancer Center and Research Institute David Straus, MD Department of Medicine Memorial Sloan-Kettering Cancer Center Chris H. Takimoto, MD, PhD Department of Pharmacology University of Texas Health Science Center at San Antonio Richard Tsang, MD Department of Radiation Oncology Princess Margaret Hospital Alan Valentine, MD Department of Neuro-Oncology M. D. Anderson Cancer Center Rena Vassilopoulou-Sellin, MD Department of Endocrine Neoplasia and Hormonal Disorders M. D. Anderson Cancer Center Akila Viswanathan, MD Department of Radiation Oncology Dana-Farber Cancer Institute Madhuri Vithala, MD Division of Medical Oncology University of Vermont

Lawrence D. Wagman, MD Division of Surgery The Center for Cancer Prevention and Treatment, St. Joseph Hospital Sharon M. Weinstein, MD Department of Anesthesiology Huntsman Cancer Institute University of Utah Lawrence M. Weiss, MD Division of Pathology City of Hope National Medical Center Mark A. Weiss, MD Department of Medicine/ Leukemia Service Memorial Sloan-Kettering Cancer Center Mitchell Weiss, MD Department of Radiation Oncology Monmouth Medical Center Jeffrey Weitzel, MD Department of Clinical Cancer Genetics City of Hope National Medical Center William G. Wierda, MD, PhD Department of Leukemia M. D. Anderson Cancer Center
Jane N. Winter, MD Division of Hematology/Oncology Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine/ Northwestern University Joachim Yahalom, MD Department of Radiation Oncology Memorial Sloan-Kettering Cancer Center Alan W. Yasko, MD Department of Orthopaedic Oncology Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine/ Northwestern University Sriram Yennurajalingam, MD Department of Palliative Care and Rehabilitation Medicine M. D. Anderson Cancer Center Sally Yowell Barbour, PHARMD Department of Medical Oncology Duke University Medical Center

 

 
 
Cara H. Glynn
Sr. Editorial Director
Angela Cibuls
Project Manager
Susan Reckling
Managing Editor
Stacey Cuozzo
Production Editor
Terri Gelfand
Sr. Editorial Coordinator
Lisa Katz
Creative Director
Andrew Barkus
Group Production Manager
Beth Scholz
Group Vice President

 

Recent Videos
9 Experts are featured in this series.
Vinay K. Puduvalli, MD, is featured in this series.
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
An advanced computation linguistics model that can detect pancreatic cysts can help patients prevent pancreatic tumors from forming.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
Related Content